ArticleKidney international reports2026

Target Trial of Glucagon-Like Peptide-1 Agonists versus Dipeptidyl Peptidase-4 Inhibitors and Mortality in Hemodialysis.

Dustin Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.